Summary
The labelling of rat cerebral cortex α2-adrenoceptors with [3H]-yohimbine ([3H]-YOH) was investigated. At 25° C, binding equilibrium was reached in about 10 min and dissociation occurred with a half time of about 1 min. Saturation experiments gave an equilibrium K D value of 10.13±1.95 nM and a maximum number of sites of 254±22 fmol/mg protein. The [3H]-YOH binding sites exhibited α2-adrenergic receptor specificity; the order of potency for the antagonists was rauwolscine > yohimbine ≫ prazosin > corynanthine. For the agonists, the order was: oxymetazoline > clonidine > (−)-adrenaline > (−)-noradrenaline ≫ (−)-phenylephrine. Agonists exhibited shallow curves in inhibiting [3H]-YOH binding, with pseudo-Hill coefficients (nH) of less than 1.0. These curves were shifted to lower overall affinity and steepened in the presence of 100 μM GTP. Antagonist competition curves were also shallow but GTP had no significant effect.
Divalent cations at millimolar concentrations decreased the [3H]-YOH binding: IC50 values were about 6.0, 6.8 and 0.3 mM for Ca2+, Mg2+ and Mn2+ respectively.
The maximal number of [3H]-YOH binding sites in the cortex was close to that labelled by the agonist [3H]-paraaminoclonidine ([3H]-PAC). The regional distribution of these sites in the brain, examined at a single concentration of [3H]-YOH and [3H]-PAC, showed a similar pattern except in the striatum. Taken together, the results indicate that like [3H]-PAC, [3H]-YOH labels α2-adrenoceptors in rat brain cortex. They also show that [3H]-YOH is a useful tool for the study of the high and low affinity sites.
Similar content being viewed by others
References
Bacopoulos NG (1981) High affinity stereospecific binding of [3H]-dopamine in rat brain: interaction with endogenous dopamine. Biochem Pharmacol 30:2037–2040
Cavero I, Lefebre-Borg F, Scatton B (1981) Functional and biochemical evidence for the lack of cardiac presynaptic alpha-adrenoceptor agonist properties in cirazoline (LD 3098). Br J Pharmacol 73:289P-290P
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K i) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Daiguji M, Mcltzer HY, U'Prichard DC (1981) Human platelet alpha2-adrenergic receptors: labeling with [3H]-yohimbine, a selective antagonist ligand. Life Sci 28:2705–2727
Glossmann H, Presek P (1979) Alpha-noradrenergic receptors in brain membranes: sodium, magnesium and guanyl nucleotides modulate agonist binding. Naunyn-Schmiedeberg's Arch Pharmacol 306: 67–73
Glossmann H, Hornung R (1980) Alpha-adrenoceptors in rat brain: sodium changes the affinity of agonists for prazosin sites. Eur J Pharmacol 61:407–408
Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. I. the disposition of [3H]-norepinephrine [3H]-dopamine and [3H]-DOPA in various regions of the brain. J Neurochem 13:655–669
Hoffman BB, Michel T, Mullikin Kilpatrick D, Lefkowitz RJ, Tolbert MEM, Gilman H, Fain JN (1980) Agonist versus antagonist binding to α-adrenergic receptors. Proc Natl Acad Sci USA 77:4569–4573
Hoffman BB, Dukes DF, Lefkowitz RJ (1981) Alpha-adrenergic receptors in liver membranes: Delineation with subtype selective radioligands. Life Sci 28:265–272
Hornung R, Presek P, Glossmann H (1979) Alpha-adrenoceptors in rat brain: direct identification with prazosin. Naunyn-Schmiedeberg's Arch Pharmacol 308:223–230
Kent RS, De Lean A, Lefkowitz RJ (1980) A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol Pharmacol 17:14–23
Lowry O, Rosebrough N, Farr A, Randall J (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Lynch CJ, Stéer ML (1981) Evidence for high and low affinity alpha2-receptors. J Biol Chem 256:3298–3303
Miach PJ, Dausse JP, Cardot A, Meyer P (1980) [3H]-Prazosin binds specifically to alpha1-adrenoceptors in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 312:23–26
Motulsky HJ, Shattil SJ, Insel PA (1980) Characterization of alpha2-adrenergic receptors on human platelets using [3H]-yohimbine. Biochem Biophys Res Comm 97:1562–1570
Perry BD, U'Prichard DC (1981) [3H]-Rauwolscine (α-yohimbine): A specific antagonist radioligand for brain α2-adrenergic receptors. Eur J Pharmacol 76:461–464
Rouot B, Snyder SH (1979) [3H]-Para-amino-clonidine: A novel ligand which binds with high affinity to α-adrenergic receptors. Life Sci 25:769–774
Rouot B, U'Prichard DC, Snyder SH (1980) Multiple alpha2-noradrenergic receptor sites in rat brain: selective regulation of highaffinity [3H]-clonidine binding by guanine nucleotides and divalent cations. J Neurochem 34:374–384
Starke K (1981) Alpha-adrenoceptor subclassification. Rev Phys Biochem Pharmacol 88:199–236
Starke K, Borowski E, Endo T (1975a) Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 34:385–388
Starke K, Endo T, Taube HD (1975b) Relative pre- and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn Schmiedeberg's Arch Pharmacol 291:55–78
Tharp MD, Hoffman BB, Lefkowitz RJ (1981) α-Adrenergic receptors in human adipocyte membranes: direct determination by [3H]-yohimbine binding. J Clin Endocrinol Metab 52:709–714
U'Prichard DC, Greeberg DA, Snyder SH (1977) Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha-noradrenergic receptors. Mol Pharmacol 13:454–473
U'Prichard DC, Bechtel WD, Rouot BM, Snyder SH (1979) Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine. Mol Pharmacol 16:47–60
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rouot, B., Quennedey, M.C. & Schwartz, J. Characteristics of the [3H]-yohimbine binding on rat brain α2 . Naunyn-Schmiedeberg's Arch. Pharmacol. 321, 253–259 (1982). https://doi.org/10.1007/BF00498509
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00498509